D-0172-2023 Class III Terminated

Recalled by OurPharma LLC — Fayetteville, AR

FDA drug recall D-0172-2023 was initiated by OurPharma LLC on Jan 13, 2023 and is designated Class III. Reason for recall: Short Fill: Underfilled units. The recall status is terminated (terminated Sep 20, 2024). Affected quantity: 768 cassettes.

Recall details

Product Type
Drugs
Report Date
Feb 1, 2023
Initiation Date
Jan 13, 2023
Termination Date
Sep 20, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
768 cassettes

Product description

FentaNYL Citrate 2.5mg/50mL (50mcg/mL) Injection Solution, Preservative-Free IV Injection 50mL Cassette, Rx Only, OurPharma, LLC, 2512 S. City Lake Rd., Fayetteville, AR 72701, NDC 73013-1001-01.

Reason for recall

Short Fill: Underfilled units.

Distribution pattern

IL and MO

Code information

Lots: 100122080003, Exp. 2/26/2023; 100122090001, Exp. 3/07/2023; 100122100002, Exp. 4/05/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0172-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0172-2023. Report a data issue: hello@regdatalab.com.